AllianceBernstein’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Buy
83,960
+9,110
+12% +$146K ﹤0.01% 2131
2025
Q1
$1.28M Hold
74,850
﹤0.01% 2118
2024
Q4
$1.85M Buy
74,850
+4,200
+6% +$104K ﹤0.01% 1997
2024
Q3
$2.01M Sell
70,650
-800
-1% -$22.8K ﹤0.01% 1968
2024
Q2
$1.89M Buy
71,450
+4,300
+6% +$114K ﹤0.01% 1991
2024
Q1
$2.17M Sell
67,150
-5,710
-8% -$184K ﹤0.01% 1878
2023
Q4
$3.07M Sell
72,860
-1,600
-2% -$67.4K ﹤0.01% 1715
2023
Q3
$2.86M Buy
74,460
+5,760
+8% +$221K ﹤0.01% 1685
2023
Q2
$1.3M Buy
68,700
+11,400
+20% +$216K ﹤0.01% 2137
2023
Q1
$889K Sell
57,300
-23,400
-29% -$363K ﹤0.01% 2292
2022
Q4
$1.43M Sell
80,700
-5,300
-6% -$94.1K ﹤0.01% 2096
2022
Q3
$480K Buy
86,000
+2,400
+3% +$13.4K ﹤0.01% 2662
2022
Q2
$326K Buy
83,600
+3,500
+4% +$13.6K ﹤0.01% 2841
2022
Q1
$441K Buy
80,100
+200
+0.3% +$1.1K ﹤0.01% 2723
2021
Q4
$681K Sell
79,900
-4,600
-5% -$39.2K ﹤0.01% 2608
2021
Q3
$734K Sell
84,500
-8,000
-9% -$69.5K ﹤0.01% 2607
2021
Q2
$978K Buy
92,500
+59,000
+176% +$624K ﹤0.01% 2531
2021
Q1
$537K Sell
33,500
-43,937
-57% -$704K ﹤0.01% 2619
2020
Q4
$3.58M Sell
77,437
-97,978
-56% -$4.53M ﹤0.01% 1675
2020
Q3
$6.17M Buy
175,415
+66,756
+61% +$2.35M ﹤0.01% 1234
2020
Q2
$2.65M Buy
108,659
+53,505
+97% +$1.3M ﹤0.01% 1676
2020
Q1
$858K Buy
+55,154
New +$858K ﹤0.01% 2087